RAB22A and hepatocellular carcinoma: In summary, we demonstrated, to the best of our knowledge, for the first time that RAB22A promotes carcinogenesis via m6A methylation and ceRNA network processes and is strongly linked with HCC development, poor survival, and immune infiltration.